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BACKGROUND: Northeastern peninsular state of Kelantan has an exceptionally low 
prevalence of Helicobacter Pylori infection; yet receive high volume of patients referred 
for Oesophago-gastroenteroscopy (OGDS) for upper gastrointestinal symptoms. CLO 
test is the most commonly used initial diagnostic test, but sensitivity is widely variable 
especially in the background of low prevalence. Amount of tissue biopsy and site of 
gastric biopsy may be crucial in maximizing the detection rate in this region.  
 
METHOD: 150 patients with upper gastrointestinal symptoms undergoing elective 
OGDS in Hospital Universiti Sains Malaysia (HUSM) were included. Four gastric 
mucosa biopsies were taken from each patient using a standard 2.8mm biopsy forcep, 
at the pre-pyloric region within 3cm from pylorus, each bite adjacent to each other. One 
biopsy specimen was compared with two biopsy specimens on a CLO test well, and 
positive results were recorded when there was colour change at 1 hour, 3 hour, 6 hour 
and 24 hour. The fourth specimen was sent for histopathological examination with 
Haematoxylin & Eosin staining, followed by Warthin-Starry staining as control to 
diagnose Helicobacter pylori. Data entry and analysis was done using SPSS software 
version 20. Mc Nemar’s test was used to compare the overall sensitivity of CLO test and 
sensitivity at each time between both groups to determine the earliest detection.  
 
RESULTS: Overall prevalence rate of Helicobacter pylori infection was 13.3%. 
Demographic pattern is consistent with previous local studies, but this study recorded a 
higher prevalence rate of 10.7% among Malay ethnic patients. Presentation with black 
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tarry stool has the highest prevalence rate of infection at 22.2%, whereas endoscopic 
diagnosis of gastric ulcer has the highest prevalence rate of infection at 32%. Overall 
sensitivity of both group were equal at 75% with no statistical significance. However, 
speed of CLO test becoming positive was slightly higher in two biopsy group at 1 hour 
and 3 hour, recording sensitivities of 37.5% and 68.8% respectively, compared to single 
biopsy group with sensitivities of 25.0% and 37.5% respectively, without any statistical 
significance.  
 
CONCLUSION: This study confirmed the low prevalence of Helicobacter pylori infection 
in this region but suggested that the method applied may improve the detection rate, 
particularly among ethnic Malay population with low bacterial load in their gastric 
mucosa. Sensitivity of CLO test is similar with either single or double biopsy specimens, 
but speed of CLO test becoming positive appeared to be slightly higher with double 
biopsy specimens, even though statistically not significant. Both presenting symptoms 
and endoscopic diagnosis are poor indicator of Helicobacter pylori status in this region. 











LATARBELAKANG: Negeri Kelantan yang terletak di timur utara Semenanjung 
Malaysia mempunyai prevalen jangkitan Helicobacter Pylori yang sangat rendah. 
Namun demikian, bilangan pesakit yang mengalami gejala penyakit gastrousus atas 
serta dirujuk untuk Oesophago-gastroduodenoscopy (OGDS) adalah tinggi. Ujian CLO 
merupakan kaedah yang paling biasa digunakan untuk mencapai diagnosis, walaupun 
sensitivitinya berubah secara meluas terutama sekali dalam populasi yang berprevalen 
rendah. Jumlah biopsi tisu dan tempat biopsi gastrik dijangka penting untuk 
meningkatkan kadar pengesanan di kawasan ini. 
KAEDAH: 150 pesakit yang mengalami gejala gastrousus atas menjalani penyiasatan 
OGDS secara elektif di Hospital Universiti Sains Malaysia (HUSM) menyertai kajian ini. 
Empat biopsi mukosa gastrik diperoleh daripada setiap pesakit dengan menggunakan 
forcep biopsi standard 2.8mm. Lokasi biopsi ditetapkan di kawasan pra-pyloric, dalam 
lingkungan 3cm daripada pylorus, setiap biopsi adalah bersebelahan antara satu sama 
lain. Satu spesimen biopsi dibandingkan dengan dua spesimen biopsi dalam kit ujian 
CLO. Keputusan positive dicatatkan apabila terdapat perubahan warna pada 1 jam, 3 
jam, 6 jam and 24 jam. Specimen keempat dihantar untuk pemeriksaan histopatologi. 
Pewarnaan Haematoxylin & Eosin diikuti dengan pewarnaan Warthin-Starry digunakan 
sebagai kawalan untuk mengesahkan diagnosis jangkitan Helicobacter pylori. Perisian 
SPSS versi 20 digunakan untuk kemasukan data and analisis. Ujian Mc Nemar 
digunakan untuk membandingkan antara 2 kumpulan dari segi sensitiviti ujian CLO 
secara keseluruhan dan sensitiviti pada setiap waktu yang ditetapkan bagi menentukan 
pengesanan terawal.  
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KEPUTUSAN: Prevalen jangkitan Helicobacter pylori pada keseluruhan adalah 13.3%. 
Corak demografi adalah konsisten dengan kajian-kajian tempatan sebelum ini. Kajian 
ini mendapati kadar prevalen adalah lebih tinggi di kalangan pesakit berbangsa Melayu, 
iaitu pada 10.7%. Pesakit yang mengalami gejala najis hitam mempunyai kadar 
prevalen yang tertinggi pada 22.2%. Dari segi diagnosis endoscopi, ulser gastrik 
mempunyai kadar prevalen tertinggi pada 32%. Sensitiviti secara keseluruhan untuk 
kedua-dua kumpulan adalah sama iaitu 75% dan tidak menunjukkan pengertian statistik 
yang bermakna. Namun demikian, kelajuan ujian CLO menjadi positif adalah lebih tinggi 
dalam kumpulan 2 biopsi pada jam pertama and ketiga, dengan sensitiviti 37.5% dan 
68.8% masing masing, di mana pada waktu yang sama, sensitiviti dalam kumpulan 1 
biopsi adalah 25% dan 37.5% masing-masing. Keputusan ini tidak menunjukkan 
pengertian statistik yang bermakna.  
 
KESIMPULAN: Kajian ini mengesahkan prevalen jangkitan Helicobacter pylori adalah 
rendah di rantau ini. Walau bagaimanapun, kajian ini menunjukkan bahawa kaedah 
yang digunakan berpotensi meningkatkan kadar pengesanan jangkitan ini, terutamanya 
di kalangan populasi berbangsa Melayu yang sememangnya mempunyai beban 
bakteria yang rendah dalam mukosa gastrik. Sensitiviti ujian CLO adalah sama bagi 
satu mahupun dua biopsi, tetapi kelajuan ujian CLO menjadi positif adalah lebih untuk 
kumpulan dua biopsi tanpa menunjukkan pengertian statistik yang bermakna. Jenis 
gejala gastrousus atas dan diagnosis endoskopi bukan penunjuk status Helicobacter 
Pylori yang tepat di rantau ini. Prevalen jangkitan berdasarkan distribusi kaum adalah 
konsisten dengan corak taburan kebangsaan.  
x 
 
TABLE OF CONTENTS 
 
 CONTENT PAGE 
 ACKNOWLEDGEMENT i 
 ABBREVIATIONS ii 
 LIST OF FIGURES iii 
 LIST OF TABLES iv 
 ABSTRACT v 
 ABSTRAK vii 
 TABLE OF CONTENTS ix 
1 INTRODUCTION…………………………………………………………………………………………………………… 1 
2 LITERATURE REVIEW 
2.1) Regional H pylori prevalence and previous local studies…………….………………………… 
2.2) Histopathological examination and special staining…………………………………………….. 
2.3) CLO test……………………………………………………………………………………………………………….. 
2.4) Site of endoscopic biopsy…………………………………………………………………………………….. 
2.5) Type of endoscopic biopsy forceps………………………………………………………………………. 









3 OBJECTIVES OF STUDY…..……………………………………………………………………………………………. 12 
4 RESEARCH QUESTIONS………..……………………………………………………………………………………… 13 
5 HYPOTHESIS………………………………………………………………………………………………………………… 14 
6 METHODOLOGY 
6.1) Patient selection………………………………………………………………………………………………….. 
6.2) Duration of study…………………………………………………………………………………………………. 
6.3) Consent for study………………………………………………………………………………………………… 
6.4) Sampling method…………………………………………………………………………………………………. 
6.5) Sample size calculation………………………………………………………………………………………… 
6.6) Study protocol……………………………………………………………………………………………………… 
6.7) Results…………………………………………………………………………………………………………………. 












7.1) Demographic pattern of study sample………………………………………………………………… 
7.2) Prevalence in current study…………………………………………………………………………………. 
7.3) Prevalence rate based on demographic categories……………………………………………… 
 
7.4) Comparing sensitivity…………………………………………………………………………………………… 



















10 LIMITATIONS OF STUDY…………………………………………………………………………………………….. 66 
11 RECOMMENDATIONS………………………………………………………………………………………………… 68 
12 REFERRENCES…………………………………………………………………………………………………………….. 70 




1.  INTRODUCTION 
 
Helicobacter Pylori was discovered by Warren and Marshall in 1982 (Marshall and 
Warren, 1984). It is a gram negative campylobacter like bacteria that 
predominantly colonizes human gastric epithelium and is one of the most common 
gastric infections worldwide (Malfertheiner et al., 2009). Over the last 3 decades, 
many different diagnostic tools have been developed. Diagnostic methods can be 
divided into invasive and non-invasive methods. Invasive methods include 
endoscopy and biopsy for either rapid urease test or histopathological staining, 
whereas non-invasive methods includes urea breath test, serology and stool 
antigen test (El-Zimaity, 2000; Ji and Li, 2014; Malfertheiner et al.,2009).  
 
Campylobacter-like Organism (CLO) test is the most commonly used rapid urease 
test for gastric biopsy specimen and is the initial test of choice for diagnosis of 
Helicobacter Pylori at endoscopy (Stabile et al., 2005; Malfertheiner et al., 2007). It 
incorporates a gel containing urea, with phenol red as a pH indicator. Biopsy 
specimen is inoculated and allowed to incubate. If Helicobacter pylori organisms 
are present in the patient’s sample, urease will hydrolyze the urea in the gel 
leading to an accumulation of ammonium ions (NH4+). This causes a rise in pH 
which is detected by a pH indicator in the test system changing from yellow to 




Gastric biopsy for CLO test is done using non-needle biopsy forceps, includes only 
part of mucosal layer, which is sufficient for diagnosis of H. Pylori as these 
microorganisms reside at the superficial mucosal layer only. There is no evidence 
that obtaining deeper biopsy (i.e. to include the submucosal layer) will improve the 
yield of H. Pylori organisms (El-Zimaity, 2000; Bernstein et al., 1995). Therefore, it 
is well established that gastric biopsy for CLO testing requires only a non-needle 
biopsy forcep. There is a wide range of non-needle biopsy forceps, ranging from 
small 1.8mm diameter forcep suitable for paediatric size flexible endoscopes or 
transnasal OGDS to large ‘jumbo’ size forceps with 3.3mm forceps (Bernstein et al., 
1995). 
 
The ideal test for diagnosis of H. Pylori at endoscopy should have excellent 
sensitivity, specificity, cost-effective and provides rapid results. This will benefit 
both physicians and patients as diagnosis and treatment can be given to patients 
immediately on the day of endoscopy (Malfertheiner et al., 2007; Laine et al., 
1996). Therefore, it should be of great interest for most researchers and clinicians 
to study on all possible variables to ensure this diagnostic test is of excellent value. 
Of the factors mentioned above, sensitivity of CLO test is still of great research 
interest as it ranges from as low as 75% to as high as 93% (Stabile et al., 2005; 
Laine et al., 1996; Yousfi et al., 1996). This leads to concern of higher rates of false 




One of the major concerns is the variability of equipments and endoscopic biopsy 
method used is various endoscopic units. Many studies have been carried out to 
standardize the technique and strategy of obtaining gastric biopsy to optimize the 
sensitivity of rapid urease testing (Yousfi et al., 1996; El-Zimaity, 2000; Stolte and 
Meining, 2001; Jeon et al., 2012; Laine et al., 1996). 
 
The overall improvement of CLO test sensitivity will benefit health care system in 
general, and specifically by: 
1. Improving the rate of detection of H. Pylori infection among patients 
presented with dyspepsia, thereafter eradication therapy can be instituted 
immediately. Most recent clinical practice guidelines advocate starting 
eradication therapy immediately during the day of endoscopy (Stabile et al., 
2005; Malfertheiner et al., 2007). 
2. Effective eradication strategy can reduce the risk of future complication, 
reduce the time of follow-up and reduce the need for repeat OGDS (Stabile 
et al., 2005). 
3. Improving the technique of endoscopic biopsy for diagnosis of Helicobacter 
Pylori, whereby the reliance on more time consuming histopathological 
examination can be significantly reduced (Stabile et al., 2005; El-Zimaity, 
2000). 
 
In the last 10 years, 2 studies have been carried out in Hospital Universiti Sains 
Malaysia to determine the local prevalence of H. Pylori infection using endoscopic 
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biopsy as the main diagnostic modality. Both studies reported exceptionally low 
prevalence compared to regional and worldwide prevalence (Sasidharan et al., 
2008; Yeh et al., 2009). As we are still struggling to explain the reason for such low 
prevalence, we are faced with a large burden of patients under Hospital Universiti 
Sains Malaysia presenting with significant upper gastrointestinal symptoms such 
as epigastric burning pain, dyspepsia and malaena. Endoscopy Unit in Hospital 
Universiti Sains Malaysia have performed between 350 and 400 elective upper 
oesophageal-gastroduodenoscopies (OGDS) per year from 2010-2012 (3 years). 
 
This study will revisit the endoscopic biopsy technique and diagnostic modalities of 
H. Pylori commonly used in this hospital, and explore the possibilities of improving 
the diagnostic yield of these modalities to improve detection rate in a background 














2.  LITERATURE REVIEW 
 
2.1  REGIONAL HELICOBACTER PYLORI PREVALENCE AND PREVIOUS 
LOCAL STUDIES 
 
Global prevalence of Helicobacter Pylori infection is in the range of 40% - 56% (El-
Zimaity, 2000; Stabile et al., 2005; Malfertheiner et al., 2007). In Malaysia, there is 
a geographical and racial variation in prevalence of Helicobacter Pylori infection 
(Kaur and Naing, 2003; Goh, 1997; Sasidharan et al., 2008; Yeh et al., 2009). Goh 
et al., 1997 reported a prevalence of 49% diagnosed by endoscopic rapid urease 
test or histopathology, with Malay 16.4%, Chinese 48.5% and Indian 61.8%. A 
study of Northern Peninsular Malaysia population found that the prevalence is 
much lower at 23.5% reported by Sasidharan et al., 2008. In the population of 
Kelantan, 2 studies were carried out in Hospital Universiti Sains Malaysia (HUSM) 
within the last 10 years, showing exceptionally low prevalence of Helicobacter 
Pylori infection. Yeh et al., 2009 reported 6.8% prevalence and Kaur and Naing, 
2003 reported 13.5%. 
 
In Yeh et al., 2009, 234 patients presented with upper gastrointestinal symptoms 
underwent OGDS, whereby endoscopic biopsy was taken from sites with 
endoscopic features of gastritis. It was noted that nearly half of the patients has 
histological diagnosis of chronic atrophic gastritis, which is associated with lower 
yield of Helicobacter Pylori organism. Kaur and Naing, 2003 studied on 52 patients, 
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whereby biopsies where taken at anterior and posterior wall of gastric antrum, 
according to the previous Sidney’s system recommendation. 
 
According to El-Zimaity, 2000, when atrophic changes occur, an environment that 
is unfavorable to the growth of H. pylori develops, and the organism can be found 
in a small percentage of endoscopic biopsy specimens. The yield for H. pylori 
infection is reduced when intestinal metaplasia is present, emphasizing the 
importance of obtaining biopsy specimens from the antrum and the corpus. This 
may explain the exceptionally low prevalence of Helicobacter Pylori infection from 
the above two studies 
 
2.2  HISTOPATHOLOGICAL EXAMINATION AND SPECIAL STAINING 
 
Gold standard for diagnosis of H Pylori is endoscopic biopsy and histopathological 
examination with special staining. Sensitivity and specificity of this diagnostic 
method ranges from 90% to 100% (El-Zimaity, December 2000; Cohen and Laine, 
1997; Ji and Li, 2014). There are several special stainings used for confirmation of 
Helicobacter pylori, i.e Giemsa stain, Genta stain, Warthin-Starry stain, Diff-Quik 
stain and El-Zimaity staining, with equal sensitivity and specificity (El-Zimaity, 
December 2000). However, histopathological diagnosis requires longer time and 






2.3  CLO TEST  
 
Eradication therapy of H. Pylori can be started based on endoscopic biopsy with 
positive rapid urease test kits i.e. CLO Test (Stabile et al., 2005; Malfertheiner et al., 
2007). This is especially for patients who presents to endoscopy without pre-
treatment. It is recommended as first line diagnostic test for endoscopically 
investigated patients. Overall CLO test sensitivity ranges from 75% to 93% and 
specificity from 95% to 100% (Stabile et al., 2005; Yousfi et al., 1996; Laine et al., 
1996). The reason for such a wide range of sensitivity is believed to be largely 
attributed to wide variability of technique and procedure of obtaining specimen for 
testing. Factors that influence the sensitivity of CLO test to gastric biopsy specimen 
are 1) sites of biopsy specimen, 2) number, and 3) size of biopsy specimen (El-
Zimaity, December 2000). 
 
2.4  SITE OF ENDOSCOPIC BIOPSY 
 
Site of biopsies have been extensively studied. One prominent author proposed 3 
biopsy specimens; one each from corpus-antrum junction, mid-corpus of greater 
curvature & antrum of greater curvature (El-Zimaity, 2000). Another prominent 
guideline, the updated Sidney’s system proposed 2 biopsies from antrum, 2 
biopsies from corpus and 1 biopsy from incisura (Stolte and Meining, 
2001). Prepyloric region is the most common region being sampled as it has a false 
negative rate of less than 3% in detection of helicobacter pylori as applied by Laine 
and colleagues, where biopsies were taken contiguously at the pre-pyloric region, 
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approximately 3cm from pylorus, without any specific aspect of the wall (Genta and 
Graham, 1994). 
 
Using the biopsy method proposed and practiced by Laine and colleagues, this 
study is looking to determine the optimal amount of gastric mucosa tissue to be 
taken at specified sites recommended above endoscopically, therefore improving 
the sensitivity of rapid urease CLO test. By answering this question, we will be able 
to recommend a standardized procedure to obtain optimal tissue mass specifically 
for rapid urease test biopsy.  
 
2.5  TYPE OF ENDOSCOPIC BIOPSY FORCEPS 
 
Biopsy for rapid urease test only requires specimen consist of partial thickness 
mucosa, therefore only non-needle forceps will be considered in our review. Types 
of forceps range from small forceps which fits into transnasal oesophago-
gastroduodenoscope with diameter of 1.8mm to large jumbo-size forceps with 
diameter of 3.3mm (Bernstein et al., 1995). It is well documented that larger 
diameter forceps are able to obtain tissue specimens with larger dimension and 
mass. A 3.3mm diameter jumbo forcep yields approximately double the volume of 
a standard 2.8mm biopsy forcep (Yousfi et al., 1996), (Laine et al., 1996; Jeon et 
al., 2012; Bernstein et al., 1995). According to Danesh et al., 1985 who studied 
extensively on various types of biopsy forceps, a jumbo size forcep is able to 
obtain a mean tissue mass of 15.51mg with SD of 2.09mg, whereas a standard 
cup 2.8mm diameter forcep, such as the one used in HUSM Endoscopy Unit, can 
9 
 
obtain a mean tissue mass of 5.93mg with SD of 0.71mg. Therefore, selection of a 
large diameter forcep can significantly increase the mass of tissue specimen 
(Bernstein et al., 1995; Danesh et al., 1985; Siddique et al., 2008). A jumbo size 
forcep would require a large working channel of at least 3.4mm diameter, which is 
not available in a lot of endoscopy units, including HUSM. Another method of 
obtaining large mass of tissue specimen is by increasing the number of biopsies, in 
other words, repeated biopsy on the same site using the same forcep. 
 
2.6  FOCUS OF STUDY: SIZE AND NUMBER OF ENDOSCOPIC BIOPSY 
 
We embark to study on the optimal size or number of gastric biopsy specimen to 
achieve the best sensitivity rate for rapid urease test. Therefore, a search of 
studies regarding the relationship of biopsy size or number and CLO test sensitivity 
is done on several reputable databases. Evidence for this postulation is inadequate 
as only 4 studies being published so far, with conflicting results. 
 
Yousfi et al., 1996 on the contrary, concluded that the diagnostic yield of rapid 
urease test is not adversely affected by small biopsy specimen. This study reported 
overall slight increase of sensitivity of large biopsy specimen (92.1%) to CLO test 
compared to sensitivity of small biopsy specimen (88.5%) by directly comparing the 
sensitivity rates without statistical analysis. This study compared specimen taken 
with 1.8mm forcep and 3.3mm forcep.  
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Jeon et al., 2012 compared rates of positive CLO test for specimens taken from 
1.8mm forcep and 2.2mm forcep via transnasal OGDS in 100 patients. This study 
reported their results in terms of rate of positive CLO test in two arms. Rate of 
positive CLO test for biopsies taken with 1.8mm forcep was 33% compared to 
biopsies taken with 2.2mm forcep at 58%. Using Kappa statistic, ƙ value was 0.83 
and p-value of 0.001. They concluded that the concordance rate of different biopsy 
size in relation to rate of positive CLO test was significant. 
 
The 2 studies above were able to demonstrate slight increase in sensitivity or rate 
of positive CLO test when using large forcep compared to using smaller forcep. 
However, both studies use small caliber forceps via transnasal flexible endoscopy, 
which is not a common practice in our local endoscopy units. Both used different 
combinations of forcep sizes, making comparison slightly difficult. An indirect 
conclusion is that sensitivity of CLO test is related to the amount of tissue 
specimen obtained.  
 
A more significant study was conducted by Loren Laine from University of 
Southern California, which studied on 102 patients, whereby biopsy specimens 
were taken with 2 types of forcep: 2.8mm and 3.3mm forceps to obtain 2 different 
sizes of mucosa tissue. They found that single bite using large forcep results in 
sensitivity of 80% compared to sensitivity of 75% from single bite with small forcep 
(p-value of 0.002). It is also found that sensitivity improved to 79% if 2 biopsies 
were taken using the small forcep (p-value of 0.001). This study concluded that 
increasing the size or number of tissue specimen for gastric mucosa biopsy will 
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increase the sensitivity of CLO test and will hasten the time to positivity of CLO test, 
and that multiple small biopsies are equivalent to single large biopsy in terms of 
CLO test sensitivity and time to positivity (Laine et al., 1996). 
 
Another significant study compared 1, 2, 3 and 4 biopsies taken at prepyloric 
antrum and tested the time taken to achieve positive CLO test. All biopsy were 
taken using standard size forcep. They concluded that the sensitivity of CLO test 
was increased by the number of biopsies taken and the time to achieve positive 
CLO test was shortened by increased number of biopsies. Sensitivity of CLO test 
was 96% when 4 biopsies were tested compared to 68% when 2 biopsies where 
tested (p-value <0.01), and 52% when 1 biopsy was tested (p-value <0.05). 
However, it should be highlighted that each arm of study were taken from different 
patients (Siddique et al., 2008). 
 
Here in HUSM, due to limitation of endoscopic equipment, biopsy by large cup 
forcep is not being done. Hence, the alternative proposed is to increase the 
number of biopsy specimen from prepyloric antrum to achieve higher yield of 
gastric mucosa tissue. It is believed that larger amount or mass of gastric mucosa 
tissue increases the yield of Helicobacter pylori organism to be tested in CLO test 







3.  OBJECTIVES 
General objective:  
To improve the detection rate of Helicobacter Pylori using rapid urease CLO test by 
increasing the number of endoscopic biopsy at specific location of the stomach  
Specific objectives: 
1. To determine the prevalence rate of Helicobacter Pylori infection using a 
new biopsy method; by taking gastric endoscopic biopsy at specified site: 
pre-pylorus antrum, within 3cm from pylorus.  
2. To describe the prevalence rate of helicobacter pylori infection of 
demographic pattern, presenting symptoms and endoscopic diagnosis 
among patients undergoing Oesophago-gastro-duodenoscopy (OGDS) 
electively in HUSM. 
3. To determine and to compare the sensitivity of CLO test between single 
gastric biopsy and two gastric biopsy specimen 
4. To determine and to compare the earliest detection and sensitivity between 








4.  RESEARCH QUESTIONS 
1. Does the implementation of biopsy at specified site (pre-pylorus antrum, 
within 3cm from pylorus along the greater curvature) increases the 
prevalence, hence detection rate of Helicobacter Pylori infection among 
patients in Hospital Universiti Sains Malaysia?  
2. Do two gastric biopsy specimens increase the sensitivity of CLO test to 
detect H Pylori compared to single biopsy? 
3. Do testing two gastric biopsy specimens in single test kit leads to reduced 













5.  HYPOTHESIS 
Research question 1 
Alternative hypothesis (HA): Implementation of biopsy at specific site can lead to 
higher detection rate of Helicobacter Pylori infection among patients in Hospital 
Universiti Sains Malaysia 
Null hypothesis (Ho): Implementation of biopsy at specific site will not lead to 
higher detection rate of Helicobacter Pylori infection among patients in Hospital 
Universiti Sains Malaysia 
Research question 2 
Alternative hypothesis (HA): There is a significant correlation between number of 
biopsy specimen and sensitivity of CLO test 
Null hypothesis (Ho): There is no correlation between number of biopsy specimen 
and sensitivity of CLO test 
Research question 3 
Alternative hypothesis (HA): There is a significant correlation between number of 
biopsy specimen and the speed of CLO test becoming positive 
Null hypothesis (Ho): There is no correlation between number of biopsy specimen 





6.  METHODOLOGY 
 
6.1  PATIENT SELECTION 
 
This was a cross sectional study involving patients coming to Endoscopy Unit, 
Hospital Universiti Sains Malaysia (HUSM) for elective Oesophago-gastro-
duodenoscopy (OGDS) for investigation of gastroduodenal symptoms from April 
2013 to September 2014 (18 months).  
Patients were explained regarding the study by the research team and consent 
taken after fulfilling inclusion and exclusion criteria as below:  
Inclusion criteria: 
1) Patients referred for elective Oesophago-gastro-duodenoscopy (OGDS) in 
Endoscopy Unit, Hospital University Sains Malaysia (HUSM) after reviewed 
by either Gastroenterology Unit or General Surgery Teams.  
2) Patients investigated for gastroduodenal symptoms such as dyspepsia, 
gastro-esophageal reflux symptoms, acute or chronic epigastric pain, history 
of malaena or unexplained iron deficiency anaemia.  
Exclusion criteria: 
1) Patients presented with acute non-variceal or variceal upper GI bleeding, or 
actively bleeding peptic ulcers.  
2) Patients presented with perforated gastric/duodenal ulcers 
3) Patients with previous history of total or partial gastrectomy  
4) Critically ill patients, haemodynamically unstable patients or endoscopies 
done bedside in high dependency unit or intensive care unit 
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6.2  DURATION OF STUDY 
 
This is a cross-sectional study, whereby patients presented to Endoscopy Unit for 
elective ODGS from April 2013 to September 2014 (18 months) were recruited for 
the study. Patients were not required to be followed-up in this study protocol.  
 
6.3  CONSENT FOR STUDY 
 
Informed consent was taken in accordance to Declaration of Helsinki, with protocol 
and statement of informed consent approved by Ethics Committee of Universiti 
Sains Malaysia. (Appendix 1, 2 and 3) 
Each patient was explained regarding the objectives of this study, the method and 
procedure of OGDS with biopsy, as well as the risk and complication of the 
procedure. It was emphasized that their treatment and follow-up plan was not 
being interfered and all routine reporting procedure will have been made available 
to their primary treating physician or surgeon to determine further treatment and 
follow-up. 
Patients under the age of 18 years, consent was taken from their legal guardians.  
 
6.4  SAMPLING METHOD 
 
The patients were sampled according to purposive sampling where they are 
selected based on presence of symptoms requiring investigation by Oesophago-
gastro-duodenoscopy (OGDS).  
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6.5  SAMPLE SIZE CALCULATION 
 
Calculation of sample size was based on the 2nd objective, where sample size 
required for estimating sensitivity of CLO test using single biopsy versus two 
biopsy specimens was done. Calculation was done using Sample Size Calculation 
for Sensitivity and Specificity Studies with Excel 5 (written by Dr Lin Naing @ Mohd 
Ayub Sadiq, 2004). 
Single biopsy group: 
• Expected sensitivity based on literature: 0.75 (Laine et al., 1996) 
• Expected specificity based on literature: 0.85 (Laine et al., 1996) 
• Expected prevalence based on literature: 0.49 (Goh, 1997) 
• Desired precision: 0.10 
• Confidence level: 95% 
To achieve the precision of 0.10 for Sensitivity, we needed a total sample size of 
149 patients. With this sample size, the precision for Specificity will be 0.080  
Two biopsies group: 
• Expected sensitivity in this group: 0.90 (Laine et al., 1996) 
• Expected specificity based on literature: 0.85 (Laine et al., 1996) 
• Expected prevalence based on literature: 0.49 (Goh, 1997) 
• Desired precision: 0.08 
• Confidence level: 95% 
To achieve the precision of 0.08 for Sensitivity, we needed a total sample size of 
113 patients. With this sample size, the precision for Specificity will be 0.092 
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According to national statistic where prevalence for Helicobacter pylori infection 
was 49% based on Goh 1997. Therefore, a total of a total of 149 patients was 
required for this study, taking the larger number based on the above two 
calculations. Throughout the period of study from April 2013 to September 2014 
(18 months) we managed to recruit 150 patients for this study.   
 
6.6  STUDY PROTOCOL 
 
All patients included underwent Oesophago-gastroduodenoscopy (OGDS) using 
standard flexible scope Olympus H180. Gastric mucosa biopsy was taken by 
standard cup forcep Olympus FB 25K non-needle fenestrated cup.  
 
3 sets of antral gastric biopsy specimens were taken from each patient for study 
purpose. Endoscopic findings were documented. Each biopsy was taken from 
adjacent sites, all at greater curvature of gastric antrum, within 3 cm from pylorus 
as stated in the objective.  
1. First specimen: single biopsy using 2.8mm forcep: labeled as Specimen A 
2. Second specimen: 2 biopsies taken using 2.8mm forcep: labeled as 
Specimen B 
3. Third specimen: single biopsy using 2.8mm forcep: labeled as Specimen C 
Specimen A and B was applied to 2 separate CLO test reagent well. Product name: 
Clotest Rapid Urease Test Single Well (CLO 025), manufactured by Tri-Med 
Distributors Pty Ltd, Australia. Examination of the change of colour was done at 1 
hour, 3 hour, 6 hour & 24 hour by endoscopy nurse / research assistant in charge.  
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Positive results were interpreted when change of colour of reagent from yellow into 
pink, magenta or orange within 24 hour at room temperature. Negative results 
were interpreted as no change of colour (yellow) after 24 hour.  
 
Specimens labeled as C were sent for histopathological examination and special 
staining for definite diagnosis of Helicobacter Pylori infection. All specimens C were 
fixed in 10% Formalin and sent to pathology lab, where:  
• Haematoxylin &Eosin (H&E) staining was done and examined for presence 
of inflammation and identification of Helicobacter pylori bacterium. If 
bacterium was not identified on H&E staining, Warthin-Starry stain was 
applied for identification of bacterium  
• Microscopic examination by single pathologist (study pathologist) unaware 
of the CLO test results 
• If there were presence of discrepancy between pathologist report and CLO 
test, slides were examined by a 2nd pathologist who was also blinded. 











6.7  RESULTS 
 
Data was collected in a clinical research form (CRF). (Appendix 4) CLO test 
interpretation was performed by endoscopy nurse acting as research assistance 
that was well trained in performing and interpreting CLO test results. 
Histopathological conclusion was reported as presence or absence of Helicobacter 
Pylori infection. Reports were addressed to principle researcher for documentation.  
CLO test was interpreted as positive or negative for each specimen A & B. 
Research assistant recorded time of test achieving positive results at 1 hour, 3 
hour, 6 hour and 24 hour after test started for each specimens A & B.  
Patients who tested positive for either one of the test (CLO or HPE positive) were 
diagnosed as having Helicobacter Pylori infection and results forwarded to their 
primary treating physicians or surgeons for definitive treatment.  
Prevalence of Helicobacter Pylori infection was determined based on positive 
testing on either CLO testing or histopathological examination (HPE).  
 
6.8  STATISTICAL ANALYSIS 
 
Data entry, cleaning and analysis was done by using IBM SPSS Statistics version 
20. Results were presented as frequency and proportion, sensitivity and specificity.  
 
Overall prevalence were presented in percentage and is derived from the total 
number of patients diagnosed positive for Helicobacter Pylori (either CLO test or 
Histopathology positive) over the total number of patients recruited (N). Prevalence 
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rates for each demographic category, namely sex, race, endoscopic diagnosis and 
presenting symptoms were described.  
 
For objective number 3, analysis was done by comparing sensitivity of CLO test 
from both arm and tested using Mc Nemar’s test  
 
Sensitivity of CLO test using single biopsy (A)            




Sensitivity of CLO test using two biopsy (B) 





Sensitivity was determined for both groups A & B 
 
Single biopsy (A) Sensitivity (A) % 




 HPE + 
CLO + a 1 
CLO - c 1 
 (a1+c1) 
 HPE + 
CLO + a 2 




Mc Nemar’s test was performed to compare sensitivity of both groups A & B 
 
 CLO + (B) CLO – (B) 
CLO + (A)   
CLO – (A)   
 
For objective number 4, cumulative frequency and sensitivity of CLO test for each 
of the time period CLO test turned positive was calculated for both groups A & B. 
Sensitivity of CLO test for each time period between both groups were then 

















7.  RESULTS 
 
7.1  Demographic pattern of study sample 
 
A total of 150 patients were recruited in this study, with 89 (59.3%) male and 61 
(40.7%) female patients. (Figure 1) Mean age was 51.3 years with standard 
deviation of 17.3 years. The youngest patient was 13 year old and the oldest was 
89 year old. (Figure 2) Racial distribution in this study is similar to the general 
population in the state of Kelantan. The study sample consists of predominantly 
Malay at 87.3%, followed by Chinese at 10% and Indian at 0.7%. 2% of study 
sample were grouped together as others, which consist of 1 Siamese and 2 
Nigerians. (Figure 3) 
Presenting symptoms leading to decision of Oesophago-Gastro-Duodenoscopy 
(OGDS) were recorded among study sample. The most common presenting 
symptom was epigastric burning pain (50.7%), followed by history of dyspepsia 
(18.0%). 12% of patients complained of history of black tarry stool and 10% gave 
typical history of pain related to meals. Only 5.3% presented with iron deficiency 
anaemia without any pain and 4.0% complained of reflux symptoms. (Figure 4) 
OGDS findings were recorded among study sample. 32.7% of study sample had 
endoscopic antral gastritis, followed by 17.3% having pan-gastritis and 18.0% with 
both gastritis and duodenitis. Gastric ulcers were found in 16.7% of study sample 
and duodenal ulcers in 0.7%, whereas combined gastric and duodenal ulcers were 
found in 3.3% of study sample. 10% of study sample were found to have hiatal 
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hernia or esophagitis as the cause of upper gastrointestinal symptoms. 1.3% of 
elective upper endoscopy was normal. (Figure 5) 
 
 
 
 
 
 
 
 
 
 
 
